Edition:
India

Profile: Nutraplus India Ltd (NUPI.BO)

NUPI.BO on Bombay Stock Exchange

6.74INR
12:18pm IST
Change (% chg)

Rs0.31 (+4.82%)
Prev Close
Rs6.43
Open
Rs6.50
Day's High
Rs6.89
Day's Low
Rs6.10
Volume
44,710
Avg. Vol
31,592
52-wk High
Rs23.00
52-wk Low
Rs5.75

Nutraplus India Limited (NPIL) is a veteran producer of bulk drugs/active pharmaceutical ingredients (APIs), specialty chemicals and intermediates for treatment across therapeutic areas. The Company's segments include Active Pharma Ingredients & Intermediates and Pharma Equipments. The Company's core focus is on the APIs/bulk drugs and also on the pain/analgesic drugs. The Company's products include Nimesulide, Bromhexine HCL, Aceclofenac, Lumefantrine, Diclofenac Sodium, Albendazole, Artemether, Lumefantrine, Arteether Ornidazole, Mefenamic acid and Doxofylline. The Company is engaged in the contract manufacturing of intermediates. The Company produces other complex products, such as Meta Chloro Anisloe and Meta Bromo Anisole. The Company operates through its manufacturing facilities located at Tarapur, Boisar, Maharashtra.

Company Address

Nutraplus India Ltd

7-A,VAKIL VILLA
H.F. SOCIETY ROAD END
JOGESHWARI EAST
MUMBAI     400057
P: +9122.40140442
F: +9122.28212192

Company Web Links